Thought Leadership
Open the Floodgates: The Potential Impact on Litigation Against FDA if the Supreme Court Reverses or Curtails Chevron Deference
December 18, 2019
Chad Landmon and Alexander Alfano
FDLI

Axinn partner Chad Landmon and associate Alexander Alfano co-authored the FDLI article, "Open the Floodgates: The Potential Impact on Litigation Against FDA if the Supreme Court Reverses or Curtails Chevron Deference."

Click here to access the article. Shared with the permission of FDLI.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.